DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
LaFargue CJ, Dal Molin GZ, Sood AK, Coleman RL.
Exploring and comparing adverse events between PARP inhibitors.
Lancet Oncol 2019;
20: e15-28
We do not assume any responsibility for the contents of the web pages of other providers.